MR Buchanan

604 total citations
23 papers, 507 citations indexed

About

MR Buchanan is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, MR Buchanan has authored 23 papers receiving a total of 507 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Pharmacology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in MR Buchanan's work include Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Inflammatory mediators and NSAID effects (6 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). MR Buchanan is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (10 papers), Inflammatory mediators and NSAID effects (6 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). MR Buchanan collaborates with scholars based in Canada and United States. MR Buchanan's co-authors include J. Hirsh, B Boneu, Frederick A. Ofosu, CJ Carter, JG Kelton, MA Jr Gimbrone, F. Fernandez, Giancarlo Agnelli, Joanne van Ryn and BM Babior and has published in prestigious journals such as Blood and PubMed.

In The Last Decade

MR Buchanan

23 papers receiving 446 citations

Peers

MR Buchanan
MR Buchanan
Citations per year, relative to MR Buchanan MR Buchanan (= 1×) peers MA Guccione

Countries citing papers authored by MR Buchanan

Since Specialization
Citations

This map shows the geographic impact of MR Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MR Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MR Buchanan more than expected).

Fields of papers citing papers by MR Buchanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by MR Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MR Buchanan. The network helps show where MR Buchanan may publish in the future.

Co-authorship network of co-authors of MR Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of MR Buchanan. A scholar is included among the top collaborators of MR Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with MR Buchanan. MR Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buchanan, MR, et al.. (2000). Results of the BRAT study--a pilot study investigating the possible significance of ASA nonresponsiveness on the benefits and risks of ASA on thrombosis in patients undergoing coronary artery bypass surgery.. PubMed. 16(11). 1385–90. 48 indexed citations
2.
Buchanan, MR, et al.. (1999). A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding.. PubMed. 111(3). 81–9. 5 indexed citations
3.
Buchanan, MR, et al.. (1993). Prevention and treatment of thrombosis: novel strategies arising from our understanding the healthy endothelium.. PubMed. 105(11). 309–13. 10 indexed citations
6.
Buchanan, MR, et al.. (1991). Endothelial cell 13-HODE synthesis and tumor cell endothelial cell adhesion.. PubMed. 21B. 909–12. 6 indexed citations
7.
Bastida, E, et al.. (1991). Effects of endothelial cell treatment on 13-HODE and prostacyclin synthesis and its correlation with tumor cell-vascular endothelial cell adhesion.. PubMed. 11(5). 273–80. 7 indexed citations
8.
Buchanan, MR, et al.. (1991). 13-HODE synthesis in internal mammary arteries and saphenous veins: implications in cardiovascular surgery.. PubMed. 21B. 667–70. 5 indexed citations
9.
Blajchman, MA, et al.. (1991). Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.. PubMed. 117(5). 359–64. 16 indexed citations
10.
Lauri, D, et al.. (1989). Differential effects of interleukin-1 and formylmethionylleucylphenylalanine on chemotaxis and human endothelium adhesivity for A549 tumor cells.. PubMed. 60(1). 161–4. 20 indexed citations
11.
Buchanan, MR, et al.. (1985). The relative importance of thrombin inhibition and factor Xa inhibition to the antithrombotic effects of heparin. Blood. 65(1). 198–201. 10 indexed citations
12.
Buchanan, MR, et al.. (1985). Sustained thrombolysis with DNA-recombinant tissue type plasminogen activator in rabbits. Blood. 66(2). 399–401. 5 indexed citations
13.
14.
Buchanan, MR, et al.. (1983). The efficacy of various treatment modalities on aluminium associated bone disease.. PubMed. 19. 195–202. 10 indexed citations
15.
Buchanan, MR, et al.. (1982). Studies on the interaction between GP-18-0-deficient neutrophils and vascular endothelium. Blood. 60(1). 160–165. 43 indexed citations
16.
Buchanan, MR, et al.. (1982). Studies on the interaction between GP-18-0-deficient neutrophils and vascular endothelium. Blood. 60(1). 160–165. 9 indexed citations
17.
Buchanan, MR, CJ Carter, & Jessica Hirsch. (1979). Decreased platelet thrombogenecity in association with increased platelet turnover and vascular damage. Blood. 54(6). 1369–1375. 13 indexed citations
18.
Kelton, JG, J. Hirsh, CJ Carter, & MR Buchanan. (1978). Sex differences in the antithrombotic effects of aspirin. Blood. 52(5). 1073–1076. 67 indexed citations
19.
Kelton, JG, et al.. (1978). Sex differences in the antithrombotic effects of aspirin. Blood. 52(5). 1073–1076. 2 indexed citations
20.
Jörgensen, L., et al.. (1970). Renal lesions and rise in blood pressure caused by adenosine diphosphate-induced platelet aggregation in rabbits.. PubMed. 23(4). 347–57. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026